GlassScriptPhysician profile
Marc Robert Stauffer
NPI 1912913971
$14,728.43
in general payments reported to CMS, 2019-2025
39 companies · $855 in 2025
The $855 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,621 · 2020: $3,232 · 2021: $1,358 · 2022: $2,519 · 2023: $2,725 · 2024: $2,419 · 2025: $855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,998.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,893.49 | 2019-2025 | Xact, Jeti, Esprit |
| Boston Scientific Corporation | $2,153.02 | 2022-2025 | Eluvia, Jetstream Sc, Ranger |
| Penumbra, INC. | $1,340.35 | 2020-2023 | Indigo System |
| Cardiovascular Systems INC. | $1,101.65 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $864.84 | 2019-2024 | Gore Excluder Iliac Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $641.79 | 2019-2025 | Jardiance |
| Shockwave Medical, INC | $567.95 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cagent Vascular INC | $553.04 | 2023-2024 | Serrantor |
| Abiomed | $543.95 | 2020-2024 | Impella |
| Amgen INC. | $538.57 | 2020-2025 | Repatha, Repatha |
| Inari Medical, INC. | $400.95 | 2019-2021 | |
| Medtronic, INC. | $333.31 | 2023-2024 | In.Pact Admiral, Hawkone, Abre |
| Janssen Pharmaceuticals, INC | $319.21 | 2020-2024 | Xarelto |
| Celonova Biosciences, INC. | $275.39 | 2019 | |
| Amarin Pharma, INC. | $245.99 | 2019-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $220.36 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $215.04 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $186.90 | 2019-2021 | |
| Surmodics, INC. | $170.84 | 2024 | Pounce Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System |
| Welch Allyn | $159.50 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $148.23 | 2019-2022 | |
| Pfizer INC. | $127.82 | 2022-2025 | |
| Recor Medical INC | $109.47 | 2024 | Paradise Renal Denervation System |
| Merck Sharp & Dohme LLC | $96.78 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.56 | 2019-2024 | Lifevest |
| Kowa Pharmaceuticals America, INC. | $61.58 | 2019-2022 | |
| Philips North America LLC | $54.61 | 2024 | (Ck4) Mcot, (Br5) Peripheral Ivus |
| Lexicon Pharmaceuticals, INC. | $48.39 | 2023 | Inpefa |
| Angiodynamics, INC. | $32.12 | 2022 | |
| Lilly USA, LLC | $30.45 | 2025 | Zepbound, Mounjaro |
| Kiniksa Pharmaceuticals International, Plc | $29.24 | 2024 | Arcalyst |
| Cook Medical LLC | $29.02 | 2024 | Amplatz |
| Arbor Pharmaceuticals, INC. | $26.65 | 2019-2021 | |
| Bardy Diagnostics, INC. | $25.00 | 2019 | |
| Kestra Medical Technology Services, INC. | $20.49 | 2023 | Assure Wcd |
| Preventice Services, LLC | $20.22 | 2020 | |
| Lantheus Medical Imaging, INC. | $18.70 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.79 | 2019 | |
| Medicure Pharma INC. | $14.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Stauffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.